
Concarlo Therapeutics
An exciting new biotech startup developing novel therapeutics to target ER/PR+ Her2- breast cancer.
Employees
Enterprise value
$400—600k
Authorizing premium user...
An exciting new biotech startup developing novel therapeutics to target ER/PR+ Her2- breast cancer.